EFFICACY AND SAFETY OF ORAL SEMAGLUTIDE IN JAPANESE PATIENTS WITH TYPE 2 DIABETES: A POST HOC SUBGROUP ANALYSIS OF THE PIONEER 1, 3, 4 AND 8 TRIALS